Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications

Life Sciences

Volumn 61, Issue 2, 1997, Pages 75-94

  Carlsson, Arvid ^a   Hansson, Lars O ^a   Waters, Nicholas ^a   Carlsson, Maria L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Gender; Glutamate deficiency hypothesis of schizophrenia; Neurotransmitters; Psychotogenic neurocicuitries; Schizophrenia; Thalamus

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; APOMORPHINE; CHLORPROMAZINE; CLOZAPINE; DIZOCILPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HALOPERIDOL; LYSERGIDE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OLANZAPINE; PHENCYCLIDINE; QUETIAPINE; RESERPINE; RISPERIDONE; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN RECEPTOR; SERTINDOLE;

AGRANULOCYTOSIS; ANIMAL MODEL; ARTICLE; AUTOPSY; CATALEPSY; CEREBROSPINAL FLUID ANALYSIS; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MEDICAL RESEARCH; MONOAMINERGIC SYSTEM; MULTIVARIATE ANALYSIS; NONHUMAN; SCHIZOPHRENIA; THALAMUS;

ANIMALIA;

EID: 0030943091     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00228-2     Document Type: Short Survey

References (67)

1. A. CARLSSON, M. LINDQVIST, Acta Pharmacol. Toxicol. 20 140-144 (1963).
2. N.-E. ANDÉN, S.G. BUTCHER, H. CORRODI, K. FUXE, U. UNGERSTEDT, Eur. J. Pharmacol. 11 303-314 (1970).
3. H. NYBÄCK, G. SEDVALL, Eur. J. Pharmacol. 10 193-205 (1970).
4. I. CREESE, D.R. BURT, S. SNYDER, Science 192 481-483 (1976).
5. P. SEEMAN, T. LEE, M. CHAU-WONG, K. WONG, Nature 261 717-719 (1976).
6. H. HIPPIUS, Antipsychotic drugs: Pharmacodynamics and pharmacokinetics. G. Sedvall, B. Uvnäs, Y. Zotterman (Eds) 437-446, Pergamon Press, Oxford (1976).
7. H. MELTZER, Psychopharmacology. The Fourth Generation of Progress. F.E. Bloom, D.J. Kupfer (Eds) 1277-1286 Raven Press, New York (1995).
8. D. LODGE, D.J.A. ARAN, J. CHURCH, S.N. DAVIES, D. MARTIN, S. ZEMAN, Excitatory Amino Acid Transmission. T.P. Hicks, D. Lodge, H. McLennan (Eds), 83-90, Alan Liss, New York (1987).
9. E. DOMINO, E.D. LUBY, Psychopathology and Psychopharmacology, J.O. Cole, A.M. Freedman, A.J. Friedhoff (Eds), 37-50, The Johns Hopkins Univ. Press, Baltimore (1973).
10. D.R. WEINBERGER, Handbook of Schizophrenia, Vol. 1, The Neurology of Schizophrenia, H.A. Nasrallah, D.R. Weinberger (Eds), 397-406, New York, Amsterdam, Oxford: Elsevier (1986).
11. S. AKBARIAN, J.J. KIM, S.G. POTKIN, W.P. HETRICK, W.E. BUNNEY, JR, E.G. JONES, Arch. Gen. Psychiat. 53 425-436 (1996).
12. L. HEIMER, G.F. ALHEID, L. ZABORSKY, The Rat Nervous System, Vol. 1, Forebrain and Mid-brain. G. Paxinos (Ed), 37-86, Academic Press, New York, (1985).
13. L. HEIMER, J. DE OLMOS, G.F. ALHEID, L. ZABORSKY, Brain Res 87 109-165.(1991).
14. L. HEIMER, G.F. ALHEID, R.C. SWITZER, The Human Nervous System. G. Paxinos (Ed), 483-582, Academic Press, San Diego (1990).
15. A. CARLSSON, Neuropsychopharmacol, 1 179-203.(1988).
16. G. STILLE, Antipsychotic Drugs: Pharmacodynamics and Pharmacokinetics. G. Sedvall, B. Uvnäs, Y. Zotterman (Eds), 51-62, Pergamon Press, Oxford (1976).
17. P.S. GOLDMAN-RAKIC, L.D. SELEMON, Cerebral Cortex, Vol. 5, E.G. Jones, A. Peters (Eds), 447-466, Plenum Publishing Corporation, New York (1986).
18. C.A. TAMMINGA, H. KANEDA, R. BUCHANAN, B. KIRKPATRICK, G. K. THAKER, M.B. YABLONSKI, H.H. HOLCOMB, Adv. in Neuropsychiatry and Psychopharmacol. 1 99-109 (1991).
19. M. CARLSSON, A. CARLSSON, J. Neural Transm. 75 221-226 (1989).
20. A. SVENSSON, M.L. CARLSSON, Neuropharmacol. 31 513-518 (1992).
21. G. STILLE, A. SAYERS, Int. J. Neuropharm. 8 181-189 (1969).
22. A. SVENSSON, M.L. CARLSSON, A. CARLSSON, J.Neural Transm. [Gen Sect] 90 199-217 (1992).
23. M.S. STARR, B.S. STARR, J. Neural Transm. [PD Sect] 6 215-226 (1993).
24. M.S. STARR, B.S. STARR, Eur. J.Pharmacol. 250 239-246.(1993).
25. M. MORELLI, G. DI CHIARA, Eur. J. Pharmacol. 182 611-612 (1990).
26. B.V. CLINESCHMIDT, G.E. MARTIN, P.R. BUNTING, N.L. PAPP, Drug Dev. Res. 2 135-145 (1982).
27. D.W. MILLER, E. ABERCROMBIE, Brain-Res-Bull. 40(1) 57-62 (1996).
28. N. WATERS, C. LUNDGREN, L.O. HANSSON, M.L. CARLSSON, J. Neural Transm. 103 117-129 (1996).
29. M.L. CARLSSON, J. Neural Transm. [GenSect], 9 1-10 (1993).
30. J.B. PENNEY, A.B. YOUNG, Movement Disorders, 1 3-15 (1986).
31. G.E. ALEXANDER, M.D. CRUTCHER, Trends in Neurosci 13 266-271 (1990).
32. C.R. GERFEN, T.M. ENGBER, L.C. MAHAN, Z. SUSEL, T.N. CHASE, F.J. MONSMA JR, D.R. SIBLEY, Science 250 1429-1432 (1990).
33. A. SVENSSON, M.L. CARLSSON, A. CARLSSON, J. Neural Transm. [Gen Sect] 88 235-240 (1992).
34. T.H. SVENSSON, J. M. MATHÉ, J.L. ANDERSSON, G.G. NOMIKOS, B.E. HILDEBRAND, M. MARCUS, J. Clin. Psychopharmacol. 15 Suppl 1: 11S-18S (1995).
35. M. CARLSSON, A. CARLSSON, J. Neural Transm. [P-D Sect] 1 317-322 (1989).
36. M. CARLSSON, A. CARLSSON, Neural Transm.[Gen Sect], 77 65-71 (1989).
37. M. CARLSSON, A. CARLSSON, Trends in Neurosci. 13 272-276 (1990).
38. M. CARLSSON, A. CARLSSON, Schizophrenia Bulletin 16 425-432 (1990).
39. M. CARLSSON, A. SVENSSON, Pharmacol. Biochem. Behav. 3 45-50 (1990).
40. M. CARLSSON, A. SVENSSON, Life Sci. 47 1729-1736 (1990).
41. M.L. CARLSSON, A. SVENSSON, A. CARLSSON, Naunyn-Schmiedeberg's Arch. Pharmacol. 343 568-573 (1991).
42. M.L. CARLSSON, G. ENGBERG, A. CARLSSON, J. Neural Transm. [GenSect], 95 223-233 (1994).
43. A. SVENSSON, M.L. CARLSSON, J.Neural Transm. [GenSect]. 101 149-157 (1995).
44. A. SVENSSON, M.L. CARLSSON, A. CARLSSON, Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 18 1203-1218 (1994).
45. A. SVENSSON, M.L. CARLSSON, A. CARLSSON, J Neural Transm. [GenSect]. 101 127-148 (1995).
46. C. SCHMIDT, S.M. SORENSEN, J.H. KEHNE, A.A. CARR, M.G. PALFREYMAN, Life Sci. 56 2209-2222 (1995).
47. M. LARUELLE, A. ABI-DARGHAM, R. GIL, C.H. VAN DYCK, J. ERDOS, D. D'SOUSA, W. ROSENBLATT, E. MCCANCE-KATZ, Y. ZEA-PONCE, S.S. ZOGHBI, R.M. BALDWIN, P.B. HOFFER, J. KRYSTAL, D.S. CHARNEY, R.B. INNIS, Schizophrenia Res. 18 198 (1996).
48. L.O. HANSSON, N. WATERS, B. WINBLAD, C.-G. GOTTFRIES, A. CARLSSON, J. Neural Transm. [GenSect] 98 217-235 (1994).
49. B. FORNSTEDT, A. BRUN, E. ROSENGREN, A. CARLSSON, J. Neural Transm. [P-D-Sect], 1 279-295 (1989).
50. A. JABLENSKY, Schizophrenia. S.R. Hirsch, D.R. Weinberger (Eds) 206-252, Blackwell Science, Oxford (1995).
51. T.J. CROW, Schizophrenia. An Integrated View, R. Fog, J. Gerlach, R. Hemmingsen (Eds), 15-25, Munksgaard, Copenhagen (1995).
52. W.F. GATTAZ, T. GASSER, H. BECKMANN, Biol. Psychiat. 20 360-366 (1985).
53. A. CARLSSON, N. WATERS, L.O. HANSSON, Schizophrenia. An Integrated View. R. Fog, J. Gerlach, R. Hemmingsen (Eds), 332-340, Munksgaard, Copenhagen (1995).
54. H.H. KORNHUBER, J. KORNHUBER, J.S. KIM, M.E. KORNHUBER, Nervenarzt 55 602-606 (1984).
55. B. GARLAND BUNNEY, W.E. BUNNEY, JR, A. CARLSSON, Psychopharmacology: The Fourth Generation of Progress. F.E. Bloom, D.J. Kupfer (Eds) 1205-1213 (1995).
56. A, LAHTI, M.A. WEILER, P.K. COREY, D.T. WARFEL, R.A. LAHTI, A. CARLSSON, C.A. TAMMINGA, Biol. Psychiat. 39 597 (1996).
57. K. SVENSSON, E. ERIKSSON, A. CARLSSON, Neuropharmacol.32 1037-1045 (1993).
58. Z. PIRTOSEK, M. MERELLO, A. CARLSSON, G. STERN, Clin. Neuropharmacol. 16 550-554 (1993).
59. L. VERHAGEN METMAN, V.H. SETHY, J.R. ROBERTS, D. BRAVL, J.I. HOFF, M.M. MOURADIAN, T.N. CHASE, Movement Disorders 9 577-581 (1994).
60. R.L. GELLMAN, G.K. AGHAJANIAN, Soc. Neurosci. Abstracts 17 1 989 (1991).
61. C.A. TAMMINGA, J.C. CRAYTON, T.N. CHASE, Am. J. Psychiat. 135 746-748 (1978).
62. C. SONESSON, C.-H. LIN, L. HANSSON, N. WATERS, K. SVENSSON, A. CARLSSON, M.-W. SMITH, H. WIKSTRÖM, J. Med. Chem. 37 2735 (1994).
63. L.O. HANSSON, N. WATERS, S. HOLM, C. SONESSON, J. Med. Chem. 38 3121. (1995).
64. M.L. CARLSSON J.Neural Transm. [Gen Sect] 100 225 (1995).
65. P. MARTIN, N. WATERS, E.S. WATERS, A. CARLSSON and M.L. CARLSSON, Eur J Pharmacol (in press) (1997).
66. N. WATERS, A. CARLSSON, L. HANSSON, Soc. Neurosci. Abstracts 20 1, 825 (1994).
67. N. WATERS, A. CARLSSON, L. HANSSON, Soc. Neurosci. Abstracts 21 1, 749 (1995).